Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-09-18 4:35 pm Purchase |
2023-09-07 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% |
4,370,024![]() (New Position) |
Filing History |
2023-09-14 4:23 pm Purchase |
2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.700% |
1,724,390![]() (+23.27%) |
Filing History |
2023-08-17 4:52 pm Unchanged |
2023-08-10 | 13D | Rain Enhancement Technologies Holdco Inc RAIN |
BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% |
0 (Unchanged) |
Filing History |
2023-08-17 4:49 pm Unchanged |
2023-08-10 | 13D | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,623 20.800% |
0 (Unchanged) |
Filing History |
2023-08-10 4:34 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 119,284 8.200% |
119,284![]() (New Position) |
Filing History |
2023-07-06 5:23 pm Purchase |
2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY |
BIOTECHNOLOGY VALUE FUND L P | 3,470,225 9.990% |
3,470,225![]() (New Position) |
Filing History |
2023-06-30 4:41 pm Unchanged |
2023-06-27 | 13D | MoonLake Immunotherapeutics MLTX |
BIOTECHNOLOGY VALUE FUND L P | 21,751,284 35.800% |
0 (Unchanged) |
Filing History |
2023-06-30 4:33 pm Purchase |
2023-06-22 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.100% |
5,745,039![]() (+317.31%) |
Filing History |
2023-06-28 1:51 pm Sale |
2023-06-26 | 13D | CTI BioPharma Corp. CTIC |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-28,463,021![]() (Position Closed) |
Filing History |
2023-06-22 4:47 pm Purchase |
2023-06-12 | 13G | Delcath Systems, Inc. DCTH |
BIOTECHNOLOGY VALUE FUND L P | 1,561,514 9.990% |
1,561,514![]() (New Position) |
Filing History |
2023-06-05 4:45 pm Purchase |
2023-05-26 | 13G | TScan Therapeutics, Inc. TCRX |
BIOTECHNOLOGY VALUE FUND L P | 4,414,910 9.990% |
4,414,910![]() (New Position) |
Filing History |
2023-05-30 4:45 pm Purchase |
2023-05-17 | 13G | Janux Therapeutics, Inc. JANX |
BIOTECHNOLOGY VALUE FUND L P | 4,106,945 9.800% |
4,106,945![]() (New Position) |
Filing History |
2023-05-22 4:47 pm Purchase |
2023-05-11 | 13D | Pieris Pharmaceuticals, Inc. PIRS |
BIOTECHNOLOGY VALUE FUND L P | 257,623 22.000% |
161,448![]() (+167.87%) |
Filing History |
2023-03-24 4:33 pm Purchase |
2023-03-14 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 2,455,089 5.100% |
250,000![]() (+11.34%) |
Filing History |
2023-03-20 5:04 pm Purchase |
2023-03-10 | 13G | Protagonist Therapeutics, Inc. PTGX |
BIOTECHNOLOGY VALUE FUND L P | 5,025,900 9.600% |
3,775,900![]() (+302.07%) |
Filing History |
2023-03-16 4:48 pm Purchase |
2023-03-06 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,360,941 5.000% |
84,398![]() (+2.58%) |
Filing History |
2023-03-06 5:10 pm Purchase |
2023-02-24 | 13G | ASLAN Pharmaceuticals Limited ASLN |
BIOTECHNOLOGY VALUE FUND L P | 1,061,000 9.990% |
1,061,000![]() (New Position) |
Filing History |
2023-02-14 12:10 pm Sale |
2022-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,510,072 12.600% |
-16,210![]() (-0.36%) |
Filing History |
2023-02-14 12:05 pm Purchase |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
BIOTECHNOLOGY VALUE FUND L P | 2,205,089 4.600% |
240,230![]() (+12.23%) |
Filing History |
2023-02-14 12:03 pm Sale |
2022-12-31 | 13G | Galmed Pharmaceuticals Ltd. GLMD |
BIOTECHNOLOGY VALUE FUND L P | 9,665 6.900% |
-333![]() (-3.34%) |
Filing History |